Io Biotech Stock Market Value
| IOBT Stock | USD 0.38 0.01 2.70% |
| Symbol | IOBT |
Is there potential for Biotechnology market expansion? Will IOBT introduce new products? Factors like these will boost the valuation of IO Biotech. Market participants price IOBT higher when confident in its future expansion prospects. Understanding fair value requires weighing current performance against future potential. All the valuation information about IO Biotech listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
IO Biotech's market price often diverges from its book value, the accounting figure shown on IOBT's balance sheet. Smart investors calculate IO Biotech's intrinsic value - its true economic worth - which may differ significantly from both market price and book value. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. Since IO Biotech's trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.
Please note, there is a significant difference between IO Biotech's value and its price as these two are different measures arrived at by different means. Investors typically determine if IO Biotech is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, IO Biotech's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
IO Biotech 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to IO Biotech's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of IO Biotech.
| 11/21/2025 |
| 02/19/2026 |
If you would invest 0.00 in IO Biotech on November 21, 2025 and sell it all today you would earn a total of 0.00 from holding IO Biotech or generate 0.0% return on investment in IO Biotech over 90 days. IO Biotech is related to or competes with Werewolf Therapeutics, Spruce Biosciences, Adicet Bio, OUTLOOK THERAPEUTICS, Cue Biopharma, Karyopharm Therapeutics, and NRX Pharmaceuticals. IO Biotech, Inc., a clinical-stage biopharmaceutical company, develops immune-modulating cancer therapies based on the T... More
IO Biotech Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure IO Biotech's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess IO Biotech upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 13.96 | |||
| Information Ratio | 0.0151 | |||
| Maximum Drawdown | 151.49 | |||
| Value At Risk | (16.22) | |||
| Potential Upside | 13.33 |
IO Biotech Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for IO Biotech's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as IO Biotech's standard deviation. In reality, there are many statistical measures that can use IO Biotech historical prices to predict the future IO Biotech's volatility.| Risk Adjusted Performance | 0.0235 | |||
| Jensen Alpha | 0.3286 | |||
| Total Risk Alpha | (0.57) | |||
| Sortino Ratio | 0.021 | |||
| Treynor Ratio | 7.57 |
IO Biotech February 19, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0235 | |||
| Market Risk Adjusted Performance | 7.58 | |||
| Mean Deviation | 8.8 | |||
| Semi Deviation | 12.43 | |||
| Downside Deviation | 13.96 | |||
| Coefficient Of Variation | 5701.49 | |||
| Standard Deviation | 19.39 | |||
| Variance | 376.12 | |||
| Information Ratio | 0.0151 | |||
| Jensen Alpha | 0.3286 | |||
| Total Risk Alpha | (0.57) | |||
| Sortino Ratio | 0.021 | |||
| Treynor Ratio | 7.57 | |||
| Maximum Drawdown | 151.49 | |||
| Value At Risk | (16.22) | |||
| Potential Upside | 13.33 | |||
| Downside Variance | 194.89 | |||
| Semi Variance | 154.56 | |||
| Expected Short fall | (11.51) | |||
| Skewness | 4.09 | |||
| Kurtosis | 30.8 |
IO Biotech Backtested Returns
IO Biotech appears to be out of control, given 3 months investment horizon. IO Biotech retains Efficiency (Sharpe Ratio) of 0.0159, which attests that the entity had a 0.0159 % return per unit of price deviation over the last 3 months. We have found twenty-nine technical indicators for IO Biotech, which you can use to evaluate the volatility of the firm. Please utilize IO Biotech's Standard Deviation of 19.39, market risk adjusted performance of 7.58, and Semi Deviation of 12.43 to validate if our risk estimates are consistent with your expectations. On a scale of 0 to 100, IO Biotech holds a performance score of 1. The company owns a Beta (Systematic Risk) of 0.0436, which attests to not very significant fluctuations relative to the market. As returns on the market increase, IO Biotech's returns are expected to increase less than the market. However, during the bear market, the loss of holding IO Biotech is expected to be smaller as well. Please check IO Biotech's standard deviation, expected short fall, relative strength index, as well as the relationship between the maximum drawdown and rate of daily change , to make a quick decision on whether IO Biotech's current price history will revert.
Auto-correlation | 0.12 |
Insignificant predictability
IO Biotech has insignificant predictability. Overlapping area represents the amount of predictability between IO Biotech time series from 21st of November 2025 to 5th of January 2026 and 5th of January 2026 to 19th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of IO Biotech price movement. The serial correlation of 0.12 indicates that less than 12.0% of current IO Biotech price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.12 | |
| Spearman Rank Test | 0.42 | |
| Residual Average | 0.0 | |
| Price Variance | 0.01 |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for IOBT Stock Analysis
When running IO Biotech's price analysis, check to measure IO Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy IO Biotech is operating at the current time. Most of IO Biotech's value examination focuses on studying past and present price action to predict the probability of IO Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move IO Biotech's price. Additionally, you may evaluate how the addition of IO Biotech to your portfolios can decrease your overall portfolio volatility.